Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Tdap Vaccine in BMT Patients
NCT00336115Phase 4Unknown
- Sponsor
- Queen Elizabeth II Health Sciences Centre
- Start
- Jul 2006
- Modality
- Vaccines & Immunotherapeutics
01
Overview
A Phase 4 trial of acellular pertussis vaccine in pertussis, Tetanus, diphtheria, sponsored by Queen Elizabeth II Health Sciences Centre. Status: unknown.
02
Drugs
acellular pertussis vaccine
03
Conditions
pertussisTetanusdiphtheria
Beyond the preview
Go deeper on NCT00336115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00336115.